Identification of human cancer antigens by SEREX

Tsutomu Okada, Yutaka Kawakami

研究成果: Article

抄録

SEREX (serological identification of tumor antigens by recombinant cDNA expression cloning) is a powerful cDNA expression cloning technique for isolation of tumor antigens recognized by T cells using serum antibodies from cancer patients from whom it is difficult to raise tumor-reactive T cells. To efficiently identify tumor antigens, various modifications have been attempted for SEREX because of frequent isolation of antigens not associated with immune responses to tumor cells. These include use of a cDNA library made from testis, use of sera from patients who are immunized with autologous tumor-derived products who demonstrate tumor regression after treatment, and use of human IgG containing mice sera from immunodeficient mice implanted with human tumor tissues.

元の言語English
ページ(範囲)205-211
ページ数7
ジャーナルBiotherapy
18
発行部数3
出版物ステータスPublished - 2004 5

Fingerprint

Forensic Anthropology
Antigens
Neoplasm Antigens
Neoplasms
Organism Cloning
Complementary DNA
Serum
T-Lymphocytes
Gene Library
Testis
Immunoglobulin G
Antibodies

ASJC Scopus subject areas

  • Cancer Research
  • Immunology and Allergy

これを引用

Okada, T., & Kawakami, Y. (2004). Identification of human cancer antigens by SEREX. Biotherapy, 18(3), 205-211.

Identification of human cancer antigens by SEREX. / Okada, Tsutomu; Kawakami, Yutaka.

:: Biotherapy, 巻 18, 番号 3, 05.2004, p. 205-211.

研究成果: Article

Okada, T & Kawakami, Y 2004, 'Identification of human cancer antigens by SEREX', Biotherapy, 巻. 18, 番号 3, pp. 205-211.
Okada T, Kawakami Y. Identification of human cancer antigens by SEREX. Biotherapy. 2004 5;18(3):205-211.
Okada, Tsutomu ; Kawakami, Yutaka. / Identification of human cancer antigens by SEREX. :: Biotherapy. 2004 ; 巻 18, 番号 3. pp. 205-211.
@article{dfd2d9a0f1834cf6a6a2839c206f33c4,
title = "Identification of human cancer antigens by SEREX",
abstract = "SEREX (serological identification of tumor antigens by recombinant cDNA expression cloning) is a powerful cDNA expression cloning technique for isolation of tumor antigens recognized by T cells using serum antibodies from cancer patients from whom it is difficult to raise tumor-reactive T cells. To efficiently identify tumor antigens, various modifications have been attempted for SEREX because of frequent isolation of antigens not associated with immune responses to tumor cells. These include use of a cDNA library made from testis, use of sera from patients who are immunized with autologous tumor-derived products who demonstrate tumor regression after treatment, and use of human IgG containing mice sera from immunodeficient mice implanted with human tumor tissues.",
keywords = "Cancer-testis antigens, CDNA expression cloning, SEREX, T cells, Tumor antigens",
author = "Tsutomu Okada and Yutaka Kawakami",
year = "2004",
month = "5",
language = "English",
volume = "18",
pages = "205--211",
journal = "Biotherapy",
issn = "0914-2223",
publisher = "Japanese Society for Cancer Chemotherapy",
number = "3",

}

TY - JOUR

T1 - Identification of human cancer antigens by SEREX

AU - Okada, Tsutomu

AU - Kawakami, Yutaka

PY - 2004/5

Y1 - 2004/5

N2 - SEREX (serological identification of tumor antigens by recombinant cDNA expression cloning) is a powerful cDNA expression cloning technique for isolation of tumor antigens recognized by T cells using serum antibodies from cancer patients from whom it is difficult to raise tumor-reactive T cells. To efficiently identify tumor antigens, various modifications have been attempted for SEREX because of frequent isolation of antigens not associated with immune responses to tumor cells. These include use of a cDNA library made from testis, use of sera from patients who are immunized with autologous tumor-derived products who demonstrate tumor regression after treatment, and use of human IgG containing mice sera from immunodeficient mice implanted with human tumor tissues.

AB - SEREX (serological identification of tumor antigens by recombinant cDNA expression cloning) is a powerful cDNA expression cloning technique for isolation of tumor antigens recognized by T cells using serum antibodies from cancer patients from whom it is difficult to raise tumor-reactive T cells. To efficiently identify tumor antigens, various modifications have been attempted for SEREX because of frequent isolation of antigens not associated with immune responses to tumor cells. These include use of a cDNA library made from testis, use of sera from patients who are immunized with autologous tumor-derived products who demonstrate tumor regression after treatment, and use of human IgG containing mice sera from immunodeficient mice implanted with human tumor tissues.

KW - Cancer-testis antigens

KW - CDNA expression cloning

KW - SEREX

KW - T cells

KW - Tumor antigens

UR - http://www.scopus.com/inward/record.url?scp=3042800857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042800857&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:3042800857

VL - 18

SP - 205

EP - 211

JO - Biotherapy

JF - Biotherapy

SN - 0914-2223

IS - 3

ER -